GE Healthcare Named “2020 Global Company of the Year” by Frost & Sullivan for its AI-based Command Centers that Help Hospitals Make Real-time Decisions That Improve Care Delivery View more
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel), a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma View more
